Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.
Clinical trial NCT07655661 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07655661
- Sponsor
- Ming Liu
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.